We validated two predicted splicing events from TCGA data sets in representative breast cancer subtype cell lines like BT-474 (Luminal B), MDA-MB-231 (TNBC/Basal), and MDA-MB-453 (HER2+). This evidence concerns the gene ERBB2 and breast carcinoma.